A reversible, p53-dependent G(0)/G(1) cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage

被引:492
作者
Linke, SP
Clarkin, KC
Di Leonardo, A
Tsou, A
Wahl, GM
机构
[1] UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92037 USA
[2] UNIV PALERMO, DEPT CELL & DEV BIOL, PALERMO, ITALY
[3] SALK INST BIOL STUDIES, MOLEC BIOL & VIROL LAB, LA JOLLA, CA 92037 USA
关键词
p53; p21(WAF1/CIP1/SDI1); pRb; normal human diploid fibroblasts; antimetabolites; cell cycle control;
D O I
10.1101/gad.10.8.934
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cells with a functional p53 pathway undergo a G(0)/G(1) arrest or apoptosis when treated with gamma radiation or many chemotherapeutic drugs. It has been proposed that DNA damage is the exclusive signal that triggers the arrest response. However, we found that certain ribonucleotide biosynthesis inhibitors caused a p53-dependent G(0) or early G(1) arrest in the absence of replicative DNA synthesis or detectable DNA damage in normal human fibroblasts. CTP, GTP, or UTP depletion alone was sufficient to induce arrest. In contrast to the p53-dependent response to DNA damage, characterized by long-term arrest and irregular cellular morphologies, the antimetabolite-induced arrest was highly reversible and cellular morphologies remained relatively normal. Both arrest responses correlated with prolonged induction of p53 and the Cdk inhibitor p21(WAF1/CIP1/SDI1) and with dephosphorylation of pRb. Thus, we propose that p53 can serve as a metabolite sensor activated by depletion of ribonucleotides or products or processes dependent on ribonucleotides. Accordingly, p53 may play a role in inducing a quiescence-like arrest state in response to nutrient challenge and a senescence-like arrest state in response to DNA damage. These results have important implications for the mechanisms by which p53 prevents the emergence of genetic variants and for developing more effective approaches to chemotherapy based on genotype.
引用
收藏
页码:934 / 947
页数:14
相关论文
共 54 条
  • [21] MODE OF ACTION OF ALANOSINE
    GALE, GR
    SCHMIDT, GB
    [J]. BIOCHEMICAL PHARMACOLOGY, 1968, 17 (03) : 363 - &
  • [22] THE E6-GENE AND E7-GENE OF HUMAN PAPILLOMAVIRUS TYPE-6 HAVE WEAK IMMORTALIZING ACTIVITY IN HUMAN EPITHELIAL-CELLS
    HALBERT, CL
    DEMERS, GW
    GALLOWAY, DA
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2125 - 2134
  • [23] HARPER JW, 1993, CELL, V75, P805
  • [24] HENDERSON JF, 1973, NUCL METABOLISM INTR, P48
  • [25] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [26] HUANG LC, 1996, IN PRESS P NATL ACAD
  • [27] SMALL PEPTIDES ACTIVATE THE LATENT SEQUENCE-SPECIFIC DNA-BINDING FUNCTION OF P53
    HUPP, TR
    SPARKS, A
    LANE, DP
    [J]. CELL, 1995, 83 (02) : 237 - 245
  • [28] P53-DEPENDENT GROWTH ARREST OF REF52 CELLS CONTAINING NEWLY AMPLIFIED DNA
    ISHIZAKA, Y
    CHERNOV, MV
    BURNS, CM
    STARK, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3224 - 3228
  • [29] ROLE FOR CERAMIDE IN CELL-CYCLE ARREST
    JAYADEV, S
    LIU, B
    BIELAWSKA, AE
    LEE, JY
    NAZAIRE, F
    PUSHKAREVA, MY
    OBEID, LM
    HANNUN, YA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (05) : 2047 - 2052
  • [30] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
    KASTAN, MB
    ZHAN, QM
    ELDEIRY, WS
    CARRIER, F
    JACKS, T
    WALSH, WV
    PLUNKETT, BS
    VOGELSTEIN, B
    FORNACE, AJ
    [J]. CELL, 1992, 71 (04) : 587 - 597